Nolan’s Notes: Finding Your Sweet Spot
Standard of Excellence: Delivering Excellence—A Daily Goal
Knocking Down the Bone Pile: Tin Whisker Mitigation in Aerospace Applications, Part 3
Enable Injections Partners with Flex for Wearable Injector Production
February 4, 2016 | FlexEstimated reading time: 1 minute
Enable Injections Inc., the developer and manufacturer of wearable medical devices that enable easy patient self-administration of high volume injectable drugs, has entered into a product development and manufacturing partnership with Flex, the global sketch-to-scale solutions company that designs and builds intelligent products for a connected world.
As part of the deal, Enable Injections and Flex will collaborate on the design, development and production of customized wearable injector systems for pharmaceutical company products and clinical trials.
"Effective design of wearable medical devices requires that we innovate on multiple fronts, pushing the boundaries of wearable technology, medical device development, and manufacturing processes," said Paul Humphries, president of High Reliability Solutions at Flex. "With their track record of quality and innovation, Enable Injections is an ideal partner in this process. We are proud to have been selected as Enable Injections’ manufacturing partner, and thrilled to be helping bring innovative, high quality wearable medical devices to the pharmaceutical and biotech industries."
According to Enable Injections, the company's novel injectors – based on pain-free injection technology and preferred by patient panels – provide customers with numerous advantages, including:
- Subcutaneous delivery of up to 50mL doses of high volume and/or viscous biologics
- Ability to monitor compliance and capture data utilizing optional Bluetooth connectivity and a mobile app to provide a connected healthcare solution
- Passive warming of drug product, eliminating the 30-minute wait for refrigerated vials to reach room temperature
- Automated mixing and reconstitution, reducing formulation time and drug development costs
- Use of standard vials, cartridges and syringes, and existing container closures
- Facilitation of in-home therapy, reducing healthcare system costs
"Flex is the recognized leader in high volume manufacturing of body-worn injection systems. We very much look forward to partnering with Flex to satisfy pharmaceutical and biotech company requirements for high reliability, high volume manufacturing," said Michael D. Hooven, Enable Injections' president and CEO.
Share on:
Suggested Items
Flexible Printed Circuit Board Market to Reach US$40.447 Billion by 2030
07/10/2025 | Globe NewswireThe flexible printed circuit board market will grow at a CAGR of 8.28% to be valued at US$40.447 billion in 2030 from US$27.17 billion in 2025.
Taiwan PCB Industry Adopts Cautious CapEx Strategy, Eyes AI and Southeast Asia for Growth
07/10/2025 | TPCADriven by the stabilization of the global electronics market and the strong demand for AI applications, although the Taiwan printed circuit (PCB) industry is facing a trend of capital expenditure convergence for three consecutive years, its output value and operating performance continue to rise, indicating that the industry is shifting from high investment to high added value development, and the industrial structure is undergoing a steady transformation.
IBIDEN Earns Recognition in FTSE Russell ESG Indexes, Reinforcing Commitment to Sustainable Growth
07/07/2025 | IBIDENIBIDEN Co, Ltd. is pleased to announce that it has been selected for FTSE4Good Index Series for the tenth consecutive year, FTSE Blossom Japan Index for the nineth consecutive year, and FTSE Blossom Japan Sector Relative Index for the fourth consecutive year.
Symposium Review: Qnity, DuPont, and Insulectro Forge Ahead with Advanced Materials
07/02/2025 | Barb Hockaday, I-Connect007In a dynamic and informative Innovation Symposium hosted live and on Zoom on June 25, 2025, representatives from Qnity (formerly DuPont Electronics), DuPont, and Insulectro discussed the evolving landscape of flexible circuit materials. From strategic corporate changes to cutting-edge polymer films, the session offered deep insight into design challenges, reliability, and next-gen solutions shaping the electronics industry.
Flexible Electronics Market to Reach $66.9 Billion by 2032, Growing at a CAGR of 9.2% from 2025
06/30/2025 | PRNewswireThe flexible electronics market is projected to reach $66.9 billion by 2032, up from an estimated $38.4 billion in 2025, growing at a robust CAGR of 9.2% during the forecast period.